Epstein Secrets

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307430 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307329 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307228 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„